Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers

Gut

Volumn 42, Issue 4, 1998, Pages 511-516

  Emmanuel, A V ^a   Kamm, M A ^a   Roy, A J ^a   Antonelli, K ^b  

^a ST MARK S HOSPITAL   (United Kingdom)

^b Janssen Research Foundation   (United Kingdom)

Author keywords

Cisapride; Enterokinetic agents; Idiopathic constipation; Intestinal transit

Indexed keywords

CISAPRIDE; PROKINETIC AGENT; PRUCALOPRIDE; SEROTONIN 4 AGONIST; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANORECTAL PRESSURE; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE LIVER FUNCTION RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HEADACHE; HUMAN; HUMAN EXPERIMENT; INTESTINE MOTILITY; INTESTINE TRANSIT TIME; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; THORAX PAIN;

EID: 0031950380     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.4.511     Document Type: Article

References (24)

1. Pilot MA. Macrolides in roles beyond antibiotic therapy. Br J Surg 1994;81:1423-9.
2. Peeters TL. Erythromycin and other macrolides as prokinetic agents. Gastroenterology 1993;105:1886-99.
3. Catnach SM, Fairclough PD. Erythromycin and the gut. Gut 1992;33:397-401.
4. Tack J, Coremans G, Janssens J. A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders. Drug Safety 1995;12:384-92.
5. Wiseman LR, Faulds D. Cisapride: an updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 1994;47: 116-52.
6. Ramirez B, Richter JE. Promotility drugs in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1993;7:5-20.
7. Lux G, Katschinski M, Ludwig S, et al. The effect of cisapride and metoclopramide on human digestive and interdigestive antroduodenal motility. Seand J Gastroenterol 1994;29:1105-10.
8. Barone J, Jessen LM, Colaizzi JL, et al. Cisapride: a gastrointestinal prokinetic drug. Ann Pharmacother 1994; 28:488-500.
9. Van Nueten JM, Van Daele PGH, Reyntjens AJ, et al. Gastrointestinal motility stimulating properties of cisapride, a non-antidopaminergic non-cholinergic compound. In: Roman C, ed. Gastrointestinal motiliy. Hingham, MA: MTP Press, 1984:513-20.
10. Meulemans AL, Schuurkes JAJ. Is the action of cisapride on the guinea-pig ileum mediated via 5-HT, receptors? Eur J Pharmacol 1902;212:51-9.
11. Briejer MR, Meulemans AL, Bosmans J-P, et al. In vitro pharmacology of the novel enterokinetic R093877 [abstract]. Gastroenterology 1997;112:A705.
12. O'Brien JD, Thompson DG, Burnham WR, et al. Action of centrally mediated autonomic stimulation on human upper gastrointestinal transit: a comparative study of two stimuli. Gut 1987;28:960-9.
13. Chaussade S, Roche H, Khyari A, et al. Mesure de temps de transit colique (TTC): description et validation d'une nouvelle technique. Gastroenterol Clin Biol 1986;10:385-9.
14. Kamm MA. Investigating constipation. Curr Med Lit (Gastroenterol) 1992;11:3-9.
15. Kamm MA, Lennard-Jones JE. Rectal mucosal electrosensory testing. Evidence for a senory neuropathy in severe constipation. Dis Colon Rectum 1990;33:419-23.
16. Hoyle CHV, Kamm MA, Burnstock G, et al. Enkephalins inhibit neuromuscular transmission in circular muscle of the human colon via pre-junctional gammn-opioid receptors. J Physiol 1990;431:465-78.
17. Briejer MR, Meulemans AL, Wellens A, et al. R093877 dose-dependently accelerates delayed gastrointestinal emptying in conscious dngs [abstract]. Gastroenterology 1997; 112:A705.
18. Briejer MR, Ghoos R, Eelen J, et al. Serotonin 5HT, receptors mediate the R093877-induced changes in contractile patterns in the canine colon [abstract]. Gastroenterology 1997;112:A705.
19. Verhayen K, Vervaeke M, Demyttenaere P, et al. Double-blind comparison of two cisapride dosage regimens with placebo in the treatment of functional constipation: a general practice multicenter study. Curr Ther Res 1987;41:978-85.
20. Hernandez G, Troncoso G, Palencia C, et al. Double-blind dose-response study of cisapride in the treatment of chronic functional constipation. Adv Ther 1988;5:121-7.
21. Arhan P, Devroede G, Jehannin B, et al. Segmental colonictransit time. Dis Colon Rectum 1981;24:625-9.
22. Metcalfe AM, Phillips SF, Zinsmeister AR, et al. Simplilfied assessment of segmental colonic transit. Gastroenterology 1987;92:40-7.
23. Reboa G, Arnulfo G, Frascio M, et al. Colon motility and colo-anal reflexes in chronic idiopathic constipation. Effects of a novel enterokinetic agent: cisapride. Eur J Clin Pharmacol 1984;26:745-8.
24. Staiano A, Cucchiara S, Andreotti MR, et al. Effect of cisapride on chronic idiopathic constipation in children. Dig Dis Sci 1991;36:733-6.